Company: BNBX
Filing Date: 2025-12-22
Form Type: S-1/A
Source: 0001104659-25-123402
Chunk: 27

Company: BNB PLUS CORP.
Filing Date: 2025-12-22
Form: S-1/A
Chunk 27
---
-looking statements concerning our business, operations and financial performance
and condition, as well as our plans, objectives and expectations for our business operations and financial performance and condition.
Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases,
you can identify forward-looking statements by terminology such as “can”, “may”, “could”, “should”,
“assume”, “forecasts”, “believe”, “designed to”, “will”, “expect”,
“plan”, “anticipate”, “estimate”, “potential”, “position”, “predicts”,
“strategy”, “guidance”, “intend”, “budget”, “seek”, “project”
or “continue”, or the negative thereof or other comparable terminology regarding beliefs, plans, expectations or intentions
regarding the future. You should read statements that contain these words carefully because they:

| · | discuss                                                                            
 our future expectations;                                                           |
| · | contain                                                                            
 projections of our future results of operations or of our financial condition; and |
| · | state                                                                              
 other “forward-looking” information.                                               |

We believe it is important
to communicate our expectations. However, forward-looking statements are based on our current expectations, assumptions, estimates and
projections about our business and our industry and are subject to known and unknown risks, uncertainties and other factors. Accordingly,
our actual results and the timing of certain events may differ materially from those expressed or implied in such forward-looking statements
due to a variety of factors and risks, including, but not limited to, those set forth under “Risk Factors” in our Annual
Report on Form 10-K for the fiscal year ended September 30, 2025, and the following factors and risks:

| · | our                                                                                            
 expectations of future revenues, expenditures, capital or other funding requirements;          |
| · | the                                                                                            
 adequacy of our cash and working capital to fund present and planned operations and growth;    |
| · | our                                                                                            
 need for additional financing which may in turn require the issuance of additional shares      
 of Common Stock, preferred stock or other debt or equity securities (including convertible     
 securities) which would dilute the ownership held by stockholders;                             |
| · | our                                                                                            
 projections regarding our expectation that our LineaRx subsidiary will significantly narrow    
 its losses for FY26Q1 (ending December 31, 2025) and approach profitability;                   |
| · | our                                                                                            
 business strategy and the timing